Literature DB >> 5812255

Acquired circulating anticoagulants in hemophilia A.

H S Strauss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5812255     DOI: 10.1056/NEJM196910162811603

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Report of a clinical trial of a Canadian preparation of antihemophilic factor.

Authors:  A A Magnin; S E Johnson
Journal:  Can Med Assoc J       Date:  1979-08-18       Impact factor: 8.262

2.  Serum immunoglobulins in patients with congenital coagulation defects and their relatives.

Authors:  A M Mingers; C Mietens; J Ströder
Journal:  Z Kinderheilkd       Date:  1971

Review 3.  Inhibitor questions: plasma-derived factor VIII and recombinant factor VIII.

Authors:  G Bray
Journal:  Ann Hematol       Date:  1994       Impact factor: 3.673

4.  Tolerance to factor VIII inhibitors in hemophilia A patients: a French twist.

Authors:  V Pascual; J D Capra
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

5.  Lupus anticoagulant after measles.

Authors:  W Muntean; W Petek
Journal:  Eur J Pediatr       Date:  1980-08       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.